Advertisement!
3.235.140.84
For Authors
Editorial Board
Submit article
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Open Access
Purchase Single Articles
Archive
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
Subscribe
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  9, Issue 3, May-June 2022, Pages 119-123

 

Original Article

Comparative Evaluation of Effect, Onset & Duration of Intranasal Dexmedetomidine Vs Midazolam for Paediatric Sedation During Diagnostic CT Scan
Somiya Gautam1, Ashwin Sonkamble2, Poornima Sonkamble3, Usha Badole
1Senior Resident, 2,3Associate Professor, 4Professor and Head, Department of Anesthesia & Critical Care, Grant Government Medical College & Sir J J Group of Hospitals, Mumbai 400008, Maharashtra, India.
Choose an option to locate / access this Article:
Check if you have access through your login credentials.             |
|

http://dx.doi.org/10.21088/ijaa.2349.8471.9322.10

Abstract

Background: Separation anxiety among children is common and normal.Children undergoing radiological imaging studies often require sedation to avoid panic episodes & severe anxiety for induction of Anaesthesia. It is important for the child to lie still during the scanning procedure & mostly we find it difficult for the children to keep still during a CT scan, which is usually about 10–15 minutes. This study aimed at comparing and evaluating the efficacy of use of intranasally administered Dexmedetomidine Vs intranasal midazolam for paediatric sedation undergoing diagnostic CT scan studies. Methods: 100 paediatric patients within age group 1-10 years were divided into 2 groups of 50 patients each, Group I & II respectively, were given either intranasal Dexmedetomidine or Intranasal Midazolam. The depth of sedation was assessed by using University of Michigan sedation scale. Results: This study concluded that Intranasal Dexmedetomidine is superior & more effective than Midazolam for pediatric sedation.


Corresponding Author : Ashwin Sonkamble